INHIBITION OF THE SALMONELLA-TYPHI ORAL VACCINE STRAIN, TY21A, BY MEFLOQUINE AND CHLOROQUINE

被引：16

作者：

HOROWITZ, H ^{[1
]}

CARBONARO, CA ^{[1
]}

机构：

[1] WESTCHESTER CTY MED CTR,DEPT MED,DIV INFECT DIS & IMMUNOL,VALHALLA,NY 10595

来源：

关键词：

D O I：

10.1093/infdis/166.6.1462-b

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1462 / 1464

页数：3

共 10 条

[1] CHUTTANI CS, 1977, B WORLD HEALTH ORGAN, V55, P643
[2] CRYZ S J JR, 1988, Drugs of Today, V24, P349
[3] COMPARATIVE EFFICACY OF 2, 3, OR 4 DOSES OF TY21A LIVE ORAL TYPHOID VACCINE IN ENTERIC-COATED CAPSULES - A FIELD TRIAL IN AN ENDEMIC AREA
FERRECCIO, C
LEVINE, MM
RODRIGUEZ, H
CONTRERAS, R
[J]. JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (04) : 766 - 769
[4] THE HUMAN HUMORAL IMMUNE-RESPONSE TO SALMONELLA-TYPHI TY21A
FORREST, BD
LABROOY, JT
BEYER, L
DEARLOVE, CE
SHEARMAN, DJC
[J]. JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (02) : 336 - 345
[5] EVALUATION OF A UDP-GLUCOSE-4-EPIMERASELESS MUTANT OF SALMONELLA-TYPHI AS A LIVE ORAL VACCINE
GILMAN, RH
HORNICK, RB
WOODWARD, WE
DUPONT, HL
SNYDER, MJ
LEVINE, MM
LIBONATI, JP
[J]. JOURNAL OF INFECTIOUS DISEASES, 1977, 136 (06) : 717 - 723
[6] CLINICAL PHARMACOKINETICS OF MEFLOQUINE
KARBWANG, J
WHITE, NJ
[J]. CLINICAL PHARMACOKINETICS, 1990, 19 (04) : 264 - 279
[7] LEVINE MM, 1987, LANCET, V1, P1049
[8] LEVINE MM, 1990, LANCET, V336, P891
[9] ANTIBODY-RESPONSE TO PREEXPOSURE HUMAN DIPLOID-CELL RABIES VACCINE GIVEN CONCURRENTLY WITH CHLOROQUINE
PAPPAIOANOU, M
FISHBEIN, DB
DREESEN, DW
SCHWARTZ, IK
CAMPBELL, GH
SUMNER, JW
PATCHEN, LC
BROWN, WJ
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (05) : 280 - 284
[10] ORAL IMMUNIZATION AGAINST TYPHOID-FEVER IN INDONESIA WITH TY21A VACCINE
SIMANJUNTAK, CH
PALEOLOGO, FP
PUNJABI, NH
DARMOWIGOTO, R
TOTOSUDIRJO, SH
HARYANTO, P
SUPRIJANTO, E
WITHAM, ND
HOFFMAN, SL
[J]. LANCET, 1991, 338 (8774) : 1055 - 1059